Press Release
Category Added in a WPeMatico Campaign
-
Zeto Announces FDA 510(k) Clearance of Zeto New Wave™, Advancing Efficiency in Outpatient EEG
New product developed to expand access to EEG in outpatient clinics RALEIGH, N.C., April 2, 2026 /PRNewswire/ — Zeto, Inc., a…
Read More » -
Freedom Premium Finance Selects Input 1 for Premium Finance Infrastructure
WESTLAKE VILLAGE, Calif., April 2, 2026 /PRNewswire/ — Input 1 today announced that Freedom Premium Finance, LLC, a newly formed…
Read More » -
AtkinsRéalis to hold its first quarter earnings webcast and conference call and Annual Meeting of Shareholders
MONTREAL, April 2, 2026 /CNW/ – AtkinsRéalis Group Inc. (TSX: ATRL), a world-class engineering services and nuclear company with offices…
Read More » -
Edly Launches “Affordable When You Need It Most” Flight Training Loans for Aspiring Pilots
Income-based repayment better matches the pilot journey—supporting students through training and early career years as earnings ramp. NEW YORK, April…
Read More » -
PayNearMe Boosts Self-Service Adoption and Payment Completion with New PayXM™ Capabilities
New features recover abandoned payment flows; among payers who receive a re-engagement message, half return and of those, 7% complete…
Read More » -
V2X Names Mike Uster Chief Information Officer to Advance Enterprise Technology Strategy
RESTON, Va., April 2, 2026 /PRNewswire/ — V2X, Inc. (NYSE: VVX) today announced the appointment of Mike Uster as Chief…
Read More » -
PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine Learning
DELRAY BEACH, Fla., April 2, 2026 /PRNewswire/ — PanGIA Biotech, Inc. (“PanGIA”) announced a peer-reviewed clinical study published in Diagnostics, “Urine-Based…
Read More » -
Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
HyBryte™ demonstrates more rapid and robust treatment response compared toValchlor® during 12-week treatment course PRINCETON, N.J., April 2, 2026 /PRNewswire/…
Read More » -
BV Investment Partners Announces Sale of CallTower
BOSTON, April 2, 2026 /PRNewswire/ — BV Investment Partners (“BV”), a middle-market private equity firm focused on tech-enabled business services…
Read More »